Matsushita Memorial Hospital

Moriguchi, Osaka 570-8540

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment — Running, not enrolling
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early